Rochester Clinical Research is taking part in a new study evaluating an updated COVID-19 vaccine for generally healthy patients ages 50-64.
Covid-19 Vaccine Research
Age Range:
50 to 64
Gender:
Male and Female
Location:
Rochester, New York
Compensation* :
TBD
About the Study
This study will help researchers learn more about how well the new vaccine works and how people respond to it.
The study lasts about six months and includes up to six visits, which may be a mix of in-person and phone check-ins.
There is no cost to participate, and compensation is available for time and travel.
Qualifications
- Adults 50–64 years old
- Generally healthy and medically stable
*Other qualifications may apply
FEATURED STUDIES
Rochester Clinical Research (RCR) is enrolling volunteers for a research study testing an investigational pneumococcal vaccine. This study is looking […]
Rochester Clinical Research in Buffalo is conducting a research study focused on Lyme disease prevention.
Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate […]
Rochester Clinical Research is taking part in a new study evaluating an updated COVID-19 vaccine for generally healthy patients ages […]
Rochester Clinical Research is currently enrolling adults 18 years and older for a research study to learn if a series […]
Rochester Clinical Research is actively recruiting participants aged 18 and older for a study looking at a possible new way […]